Log In
BCIQ
Print this Print this
 

Hepatect CP, Zutectra

  Manage Alerts
Collapse Summary General Information
Company Biotest AG
DescriptionHuman hepatitis B immunoglobulin
Molecular Target Immunoglobulins
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent hepatitis B virus (HBV) infection; Prevent hepatitis B virus (HBV) re-infection after liver transplantation
Regulatory Designation Australia - Orphan Drug (Prevent hepatitis B virus (HBV) re-infection after liver transplantation)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today